Skip to main content

Fisher Biosciences and Dyomics to Develop Protein Products

NEW YORK, Jan. 9 (GenomeWeb News) - Fisher Biosciences will develop and manufacture protein and nucleic acid-detection products as part of a collaboration with Dyomics, Fisher said today.

 

Fisher currently offers protein-research products based primarily on chemiluminescent and colorimetric detection under its Pierce brand. Under the collaboration, the brand will include fluorescently labeled reagents

 

The parent company of Fisher Biosciences, Fisher Scientific International, recently acquired an equity interest in Dyomics.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.